A Double-Blind Crossover Study Comparing the Safety and Efficacy of Three Weeks of Flu/Sal 250/50 bid Plus Albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid Plus Albuterol/Ipratropium Bromide 2 puffs prn q4 hours in Patients with Chronic Obstructive Pulmonary Disease

Crossover Study ◽

Pulmonary Disease ◽

Ipratropium Bromide ◽

Chronic Obstructive ◽

Double Blind ◽

Safety And Efficacy ◽

Blind Crossover Study ◽

Double Blind Crossover Study

A multicenter randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of rhubarb in treating acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2016.07.002 ◽

2016 ◽

Vol 3 (2) ◽

pp. 71-80

Author(s):

Fengjie Zheng ◽

Yan Sun ◽

Xianggen Zhong ◽

Yueqi Wang ◽

Ruohan Wu ◽

...

Keyword(s):

Pulmonary Disease ◽

Acute Exacerbation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

Safety And Efficacy ◽

Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.

Thorax ◽

10.1136/thx.50.7.750 ◽

1995 ◽

Vol 50 (7) ◽

pp. 750-754 ◽

Cited By ~ 65

Author(s):

C S Ulrik

Keyword(s):

Crossover Study ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Single Centre ◽

Double Blind ◽

Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial

Academic Emergency Medicine ◽

10.1111/acem.13560 ◽

2018 ◽

Vol 26 (4) ◽

pp. 434-442

Author(s):

Kaouthar Beltaief ◽

Mohamed Amine Msolli ◽

Asma Zorgati ◽

Adel Sekma ◽

Marwen Fakhfakh ◽

...

Keyword(s):

Pulmonary Disease ◽

Acute Exacerbation ◽

Noninvasive Ventilation ◽

Ipratropium Bromide ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study to Assess the Effect of Reldesemtiv on Exercise Tolerance in Subjects with Chronic Obstructive Pulmonary Disease

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4272 ◽

2019 ◽

Cited By ~ 1

Author(s):

H.B. Rossiter ◽

R. Casaburi ◽

F.C. Sciurba ◽

J. Porszasz ◽

W.W. Stringer ◽

...

Keyword(s):

Crossover Study ◽

Pulmonary Disease ◽

Exercise Tolerance ◽

Chronic Obstructive ◽

Double Blind ◽

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

Clinical Drug Investigation ◽

10.2165/00044011-200323030-00004 ◽

2003 ◽

Vol 23 (3) ◽

pp. 181-191 ◽

Cited By ~ 4

Author(s):

Shari A. Brazinsky ◽

Robert J. Lapidus ◽

Laurence A. Weiss ◽

Mo Ghafouri ◽

Nora M. Fagan ◽

...

Keyword(s):

Pulmonary Disease ◽

Ipratropium Bromide ◽

Chronic Obstructive ◽

Safety And Efficacy ◽

One Year

Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Current Therapeutic Research ◽

10.1016/s0011-393x(03)00057-2 ◽

2003 ◽

Vol 64 (5) ◽

pp. 317-326 ◽

Cited By ~ 4

Author(s):

Leonello Fuso ◽

Raffaele Antonelli Incalzi ◽

Salvatore Basso ◽

Salvatore Spadaro ◽

Lorenzo M Tramaglino ◽

...

Keyword(s):

Crossover Study ◽

Pulmonary Disease ◽

Exercise Performance ◽

Chronic Obstructive ◽

Single Center ◽

Dry Powder ◽

Double Blind ◽

Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study

Journal of Antimicrobial Chemotherapy ◽

10.1093/jac/37.suppl_a.93 ◽

1996 ◽

Vol 37 (suppl A) ◽

pp. 93-104 ◽

Cited By ~ 28

Author(s):

L. Allegra ◽

N. Konietzko ◽

P. Leophonte ◽

J. Hosie ◽

R. Pauwels ◽

...

Keyword(s):

Multicentre Study ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Double Blind ◽

Safety And Efficacy ◽

Acute Exacerbations ◽

Comparative Safety

Faculty Opinions recommendation of The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.6692956.6849054 ◽

2010 ◽

Author(s):

Jack Satsangi

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Safety And Efficacy

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Parallel Group